Evolving Therapeutic Scenario of Stage III Non-Small-Cell Lung Cancer
Lung cancer remains the leading cause of cancer-related death with an incidence that continues to increase in both sexes and all ages. However, 80% to 90% of lung cancers are non-small cell lung cancer (NSCLC) and the remaining 10% to 20% are small cell lung cancer. Adenocarcinoma is the most common...
| Published in: | Clinical Medicine Insights: Oncology |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-02-01
|
| Online Access: | https://doi.org/10.1177/11795549231152948 |